Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT0017
Target Gene : AKT1 Host Cell : DLD-1
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT0017 |
| Description | DLD-1-AKT1 (-/-) is a cell line with a homozygous knockout of human AKT1 |
| Target Gene | AKT1 |
| Host Cell | DLD-1 |
| Host Cell Species | Homo sapiens (Human) |
| Size | >1x106 cells/vial |
| Validation | Sequencing |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | AKT1 v-akt murine thymoma viral oncogene homolog 1 [ Homo sapiens ] |
| Gene Symbol | AKT1 |
| Synonyms | AKT; PKB; RAC; PRKBA; PKB-ALPHA; RAC-ALPHA |
| Gene Description | v-akt murine thymoma viral oncogene homolog 1 |
| GeneID | 207 |
| Uni ProtID | B0LPE5 |
| mRNA Refseq | NM_001014431.1 |
| Protein Refseq | NP_001014431.1 |
| Chromosome Location | 14q32.32 |
| Function | ATP binding; ATP binding; enzyme binding; identical protein binding; kinase activity; nitric-oxide synthase regulator activity; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; protein binding; protein kinase C binding; protein kinase activity; protein serine/threonine kinase activity; protein serine/threonine kinase activity; |
| Pathway | AKT phosphorylates targets in the cytosol, organism-specific biosystem; AKT phosphorylates targets in the nucleus, organism-specific biosystem; AKT-mediated inactivation of FOXO1A, organism-specific biosystem; AMPK signaling, organism-specific biosystem; Activation of BAD and translocation to mitochondria, organism-specific biosystem; Activation of BH3-only proteins, organism-specific biosystem; Acute myeloid leukemia, organism-specific biosystem; |
| MIM | 164730 |
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The knockout and testing was done within 10 days and I really recommend this reagent, the efficiency is superb.
According to my previous method of experimentation, reagents, etc., this experiment would have taken me two months to complete, and I used this product for only one month, directly saving half the time.
Maybe it's a bit of metaphysics, I hadn't been able to get a positive result before, my teacher suggested I change the reagents from another company and I was very surprised when the result came back
The unsatisfactory results had caused me so much headache that I was tempted to give up on this part of the experiment until I used this reagent to produce good results and I realised what my problem was.
This reagent is almost as effective as a very expensive brand I have used before, but it is so cheap that it does seem to need more comparison.
With the mentality of giving it a try, I bought a small-sized knockout reagent, and after trying it once, I decided to buy other specifications of reagent and continue to use it.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.